Journal Article

A 125 bp region of the Ig V<sub>H</sub>1 promoter is sufficient to confer lymphocyte-specific expression in transgenic mice

Nicole Avitahl and Kathryn Calame

in International Immunology

Published on behalf of Japanese Society for Immunology

Volume 8, issue 9, pages 1359-1366
Published in print September 1996 | ISSN: 0953-8178
e-ISSN: 1460-2377 | DOI:
A 125 bp region of the Ig VH1 promoter is sufficient to confer lymphocyte-specific expression in transgenic mice

More Like This

Show all results sharing these subjects:

  • Immunology
  • Biological Sciences


Show Summary Details


Ig variable region (VH) promoters are active only in B cells and extinction experiments suggest that they are negatively regulated in non-B lineage cells. In contrast to the multiple transcription factor binding sites which occur in Ig enhancers, only a few functionally important transcription factor binding sites have been identified in VH promoters. In this study, we have used transgenic animals to test the functional importance of a 5' portion of the VH1 promoter which is known to contain a matrix attachment region as well as binding sites for the negative regulator NF-μNR and Bright, a protein complex which is induced upon stimulation of B cells with IL-5 and antigen. Our results show that none of these regions is required for VH1 promoter activity in the context of a rearranged μ gene. In fact, a truncated promoter extending only 125 bp upstream of the transcription initiation site was sufficient to confer strong expression in lymphocytes with negligible expression in any other tissue. These results define the smallest known region of a VH promoter which is capable of lymphold-specific activity and establish the simplicity of the VH1 promoter element.

Keywords: Ig; matrix attachment region; promoter; transgenic; VH1

Journal Article.  0 words. 

Subjects: Immunology ; Biological Sciences

Full text: subscription required

How to subscribe Recommend to my Librarian

Users without a subscription are not able to see the full content. Please, subscribe or login to access all content.